0.75mg/mL solution for infusion and 2mg/mL solution for injection
In the event of an inadvertent temperature excursion the following data may be used:
The product is stable at temperatures up to 25°C for up to one month.
Contact GSK in cases where additional stability data is required. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.
20 December 2021
London MI Service
Lactation Safety Information
Normally administered with aspirin or heparin
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties and likely to be degraded in infant’s GI tract
Consider suspending breastfeeding during eptifibatide infusion to minimise any unknown risks
15 February 2022